Leucine rich repeat kinase 2 inhibitors (University of Groningen)

N/A

Report date: 2025/01/26 19:16:30
NME

Base Information

Drug NameLeucine rich repeat kinase 2 inhibitors (University of Groningen)
Drug Alias NameLRRK2 inhibitors (University of Groningen)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLeucine-rich repeat serine/threonine-protein kinase 2 inhibitors
TargetsLeucine-rich repeat serine/threonine-protein kinase 2
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRijksuniversiteit te Groningen
China Registration ClassN/A

Develop Information

Active CompaniesRijksuniversiteit te Groningen
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A